Novartis' breast cancer drug, Afinitor receives US FDA approval pharmabiz.com Novartis has received the US Food and Drug Administration (FDA) approval for Afinitor (everolimus) tablets for the treatment of postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer (advanced HR+ breast cancer) ... |
